Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin in Febrile Neutropenia
NCT01216241Phase 3Terminated
- Sponsor
- University of Rochester
- Start
- Apr 2011
- Primary completion
- Apr 2013
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daptomycin in febrile neutropenia (FN), sponsored by University of Rochester. Started Apr 2011; status: terminated.
02
Drugs
daptomycin
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT01216241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216241.